Acetaminophen Cancer Risk To Be Evaluated Under California Prop 65 Law

California health officials may add acetaminophen, the active ingredient in Tylenol and other widely used pain medications, to a statewide list of chemicals that may cause cancer.

According to an Associated Press report published this week, the California Office of Environmental health Hazard Assessment (OEHHA) is reviewing the cancer side effects of acetaminophen, to determine whether it should be included on the state’s Prop 65 list.

If acetaminophen is added to the list, California law would require that any products sold in the state that contain the ingredient include a cancer risk label warning.

The OEHHA first announced that it is looking at acetaminophen as a potential entry to the list in a federal register notice on March 15, 2019.

On December 5, the stateโ€™s Carcinogen Identification Committee (CIC), a panel of governor-appointed scientists which reviews potential Prop 65 candidates, held a public meeting on potential inclusion of acetaminophen and released its review of the evidence.

The CIC evidence review (PDF) indicates it looked at 133 acetaminophen studies, some of which have linked the popular painkiller to cancer, while others have not. They found that metabolizing acetaminophen can cause electrophilic and genotoxic metabolites to form, and that it tested positive for a number of other genotoxicity endpoints.

The comment period on the committeeโ€™s findings ends on January 27. However, both the FDA and the World Health Organizationโ€™s International Agency for Research on Cancer (IARC) have declined to list acetaminophen as a potential cancer-causing agent, following their own reviews of the evidence over the years.

Industry associations also say they plan to fight the drugโ€™s inclusion on the list, which often has far-reaching effects beyond California, the state with the nationโ€™s largest economy.

Acetaminophen is the active ingredient in Tylenol and other cold and pain medications. While most consumers assume that the drug is safe, acetaminophen is theย leading cause for liver injury in the United States, causing an estimated 50,000 emergency room visits each year, including 25,000 hospitalizations and over 450 deaths annually. In addition, use of the medication has been linked to a risk ofย dangerous skin reactions, like Stephens-Johnson Syndrome.

In recent years, efforts have been ramped up to bring the risk of acetaminophen overdoses to the publicโ€™s attention and to reduce the amount of liver injury cases linked to the popular analgesic, which is also found in Tylenol, other pain killers and a number of cold medications.

Irvin Jackson
Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Analysts expect wider use of breast reconstruction mesh through 2030, even as lawsuits raise questions about synthetic products, FDA approval and serious complications requiring additional surgery.
Olympus faces a lawsuit from a Chicago woman who says she developed a severe, life-threatening infection due to the design of its endoscopes, which she says can trap infectious material in their cracks and crevices.
A Boston Scientific spinal cord stimulator lawsuit claims the chronic pain implants are defectively designed, causing a Louisiana woman to suffer shocks and pain, as well as dizziness and fainting spells.